|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||488.13 - 491.77|
|52-week range||488.13 - 491.77|
|Beta (5Y monthly)||1.05|
|PE ratio (TTM)||19.36|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Select Medical's (SEM) first-quarter earnings benefit from higher patient visits and sound segmental contributions to revenues, partly offset by elevated labor expenses.
Mednax (MD) continues to anticipate revenues of $2 billion and adjusted EBITDA of at least $270 million for 2022.
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...